Driven by cutting edge science, zPREDICTA offers services for screening anti-cancer therapeutic agents.
Our unique multi-component organ-specific extracellular matrix (ECM) enables accurate reconstruction of human tissue architecture driving accurate prediction of clinical outcomes.
Available models: bone marrow, breast, colon, lung, prostate, ovary, stomach.
Available indications: AML, multiple myeloma
Available tissues: bone marrow, breast, colon, lung, ovary, prostate, stomach, etc.
Available format(s): 96-well
(384-well in development)
Compatible with all standard readout methods: flow cytometry, RNAseq, in situ imaging, high content imaging, CellTiter Glo, MTS, and other readouts in your workflow.
Our team of expert scientists is ready to create custom models for any tissue of interest.
Please contact us for details.